Heinrich, Fabian Rauch, Jessica Bertram, Franziska Kempf, Volkhard A J Besier, Silke Kuta, Piotr Renné, Thomas Ondruschka, Benjamin Püschel, Klaus Tappe, Dennis
...
Published in
Infection
The number of homeless people in Germany is steadily increasing. Due to their often precarious living conditions, this specific population may be increasingly exposed to ectoparasites that can transmit various pathogens. To assess the prevalence and thus the risk of such infections, we analyzed the seropositivity of rickettsiosis, Q fever, tularemi...
Tobudic, Selma Bahrs, Christina Schneider, Lisa Paulussen, Emilia Bartonickova, Lucie Hagel, Stefan Starzengruber, Peter Burgmann, Heinz Pletz, Mathias W
Published in
Infection
This study aimed to compare treatment outcomes for bloodstream infections (BSI) caused by a piperacillin/tazobactam (PIP/TAZ)-susceptible E. coli among three patient groups: BSI caused by ampicillin/sulbactam (AMP/SLB)-resistant isolates treated with PIP/TAZ, BSI caused by AMP/SLB-sensitive isolates treated with PIP/TAZ, and BSI caused by AMP/SLB-r...
Mahajan, Ujjwal Mukund Erber, Johanna Shamsrizi, Parichehr Voit, Florian Vielhauer, Jakob Johlke, Anna-Lena Benesch, Christopher Khaled, Najib Ben Reinecke, Felix Rudi, Wolf-Stephan
...
Published in
Infection
Identification of patients at risk of complicated or more severe COVID-19 is of pivotal importance, since these patients might require monitoring, antiviral treatment, and hospitalization. In this study, we prospectively evaluated the SACOV-19 score for its ability to predict complicated or more severe COVID-19. In this prospective multicenter stud...
Keske, Şiran Akyol, Merve Tanrıöver, Cem Özlüşen, Batu Akcan, Rüştü Emre Güler, Ulaş Sait, Bilgin Kaçmaz, Bahar Gönen, Mehmet Ergönül, Önder
...
Published in
Infection
Tocilizumab, a monoclonal IL-6 receptor blocker, is an effective agent for severe-to-critical cases of COVID-19; however, its target patients for the optimum use need to be detailed. We performed a systematic review and meta-analysis to define its effect among severely ill but non-intubated cases with COVID-19. We searched PubMed, Scopus, Web of Sc...
Schlabe, Stefan Boesecke, Christoph van Bremen, Kathrin Schwarze-Zander, Carolynne Bischoff, Jenny Yürüktümen, Aylin Heine, Mario Spengler, Ulrich Nattermann, Jacob Rockstroh, Jürgen K
...
Published in
Infection
The epidemiology of HIV-infected individuals on the Medical Intensive Care Units (MICU) has changed after profound progress in treatment of AIDS-defining illnesses and anti-retroviral therapy (ART). Changes of MICU utilization of Hepatitis C (HCV) patients following roll-out of direct-acting antivirals (DAA) are yet to evaluate. We performed a retr...
Bertuccio, Paola Degli Antoni, Melania Minisci, Davide Amadasi, Silvia Castelli, Francesco Odone, Anna Quiros-Roldan, Eugenia
Published in
Infection
Oral antivirals (nirmatrelvir/ritonavir and molnupiravir), intravenous short treatment of remdesivir and anti-SARS-CoV-2 monoclonal antibodies (mAbs) have been used for early COVID-19 treatments in high risk of disease progression patients. The term long COVID has been used to refer to a range of new, returning, or ongoing symptoms after SARS-CoV-2...
Anabire, Nsoh Godwin Aculley, Belinda Pobee, Abigail Kyei-Baafour, Eric Awandare, Gordon A Del Pilar Quintana, Maria Hviid, Lars Ofori, Michael F
Published in
Infection
Anaemia remains a serious concern among pregnant women, and thus, it is closely monitored from the onset of pregnancy through to delivery to help prevent adverse maternal and neonatal outcomes. In malaria-endemic settings, continuous low-level carriage of P. falciparum parasites is common and its contribution to maternal anaemia should not be under...
Shi, Yanyan Strobl, Ralf Apfelbacher, Christian Bahmer, Thomas Geisler, Ramsia Heuschmann, Peter Horn, Anna Hoven, Hanno Keil, Thomas Krawczak, Michael
...
Published in
Infection
We aimed to assess symptoms in patients after SARS-CoV-2 infection and to identify factors predicting prolonged time to symptom-free. COVIDOM/NAPKON-POP is a population-based prospective cohort of adults whose first on-site visits were scheduled ≥ 6 months after a positive SARS-CoV-2 PCR test. Retrospective data including self-reported symptoms and...
Dey, Amit Vaishak, K Deka, Dikshita Radhakrishnan, Arun Kumar Paul, Sujay Shanmugam, Priyadarshini Daniel, Alice Peace Pathak, Surajit Duttaroy, Asim K Banerjee, Antara
...
Published in
Infection
The COVID-19 pandemic caused by the novel Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) has put the world in a medical crisis for the past three years; nearly 6.3 million lives have been diminished due to the virus outbreak. This review aims to update the recent findings on COVID-19 infections from an epigenetic scenario and develop...
Larcher, Romaric Laffont-Lozes, Paul Naciri, Tayma Bourgeois, Pierre-Marie Gandon, Cléa Magnan, Chloé Pantel, Alix Sotto, Albert
Published in
Infection
To demonstrate the feasibility of continuous infusion of meropenem-vaborbactam to optimize the treatment of carbapenem-resistant Enterobacterales. Report of a case of a Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae bloodstream infection comfirmed by whole genome sequencing and therapeutic drug monitoring (TDM) of meropenem. A pa...
